Oura buys AI doctor startup Counsel Health for $625M

Oura makes a $299 ring that tracks your heart rate and sleep. Soon it wants to treat you, too. On Nov. 10, Oura said it will pay $625 million in cash for Counsel Health. Counsel's AI chatbot already lives inside Oura's app. It can connect users to real doctors. The deal turns Oura from a company that watches your health data into one that acts on it.

Counsel Health isn't a new partner Oura just met. Its chatbot has been built into the Oura app since June. This acquisition formalizes a relationship that was already working. Counsel's CEO, Muthu Alagappan, will become Oura's chief clinical AI officer, along with the startup's roughly 70 employees. The timing matters too. Oura delayed its own IPO over market uncertainty last month. Even so, its revenue jumped 153% to $533 million. Spending $625 million now says the company still feels confident enough to make a big bet.

Keep reading — what to watch

Will people actually trust a ring company to help manage their health care? Tracking sleep and heart rate is one thing. Recommending treatment, prescribing medication, or triaging symptoms is a different kind of responsibility. It comes with real regulatory and liability stakes. Watch-and-track wearables never had to face that before. Oura is betting its hardware audience will follow it there. Whether regulators, insurers, and doctors go along is the open question.